Skip to main content
. 2011 Jul;3(4):207–218. doi: 10.1177/1758834011409000

Figure 4.

Figure 4.

Potential selection factors for customizing systemic treatment in advanced non-small cell lung cancer (NSCLC). Moving from thinking of NSCLC as a single entity towards customized treatment of a collection of tumors grouped under the term NSCLC.